Dermata Therapeutics DRMA
NASDAQ DRMA
$0.87 +0.01 (+1.16%)
At close: Oct 20, 2026 · 4:00 PM EDT

Dermata Therapeutics (DRMA) Research & Development (2020 - 2026)

Updated

Dermata Therapeutics (DRMA) posted Research & Development of $212,563 for Q2 2026, down 65.6% from $617,835 a year earlier and down 44.6% from the prior quarter.

Analysis

Dermata Therapeutics (DRMA) Research & Development (2020 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Research & Development at Dermata Therapeutics was $1.63 million, down 74.9% year-over-year; for FY2025, it came in at $2.93 million, down 64.3% from FY2024.

  • Annual Research & Development shows a five-year compound annual growth rate of 12.8% (FY2020 to FY2025).
  • In prior years, Dermata Therapeutics' Research & Development was $8.2 million in FY2024 (+101.6%), $4.07 million in FY2023 (-28.0%), $5.65 million in FY2022 (+63.4%) and $3.46 million in FY2021 (+115.2%).
  • The Q2 2026 figure stands as the lowest quarterly Research & Development since Q4 2020.
  • On a year-over-year basis, Research & Development has declined in each of the last six quarters, with an average decline of 15.1% over the last eight quarters.
  • The strongest year-over-year quarter for Research & Development in the past five years was Q4 2021, with growth of 872.7%; the weakest was Q3 2025, with a decline of 79.0%.
  • According to Business Quant data, Research & Development for the three prior quarters was $383,724 (Q1 2026), $526,620 (Q4 2025) and $504,387 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Procter & Gamble 371.53 Bn 327.28 Bn 10.28 Bn -
2 Colgate Palmolive 75.49 Bn 70.22 Bn 3.30 Bn -
3 Estee Lauder Companies 38.41 Bn 26.49 Bn 2.74 Bn -
4 Kenvue 37.04 Bn 32.65 Bn 2.30 Bn -
5 Kimberly Clark 35.98 Bn 33.18 Bn 1.60 Bn -
6 Church & Dwight 25.05 Bn 23.58 Bn 693.90 Mn -
7 Clorox 10.64 Bn 8.92 Bn 804.00 Mn 32.00 Mn
8 e.l.f. Beauty 6.78 Bn 5.75 Bn 398.84 Mn -
9 Reynolds Consumer Products 4.84 Bn 4.50 Bn 245.00 Mn -
10 Dermata Therapeutics 3.42 Mn 3.42 Mn - 212,563.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 212,563.00
Mar 31, 2026 383,724.00
Dec 31, 2025 526,620.00
Sep 30, 2025 504,387.00
Jun 30, 2025 617,835.00
Mar 31, 2025 1.28 Mn
Dec 31, 2024 2.19 Mn
Sep 30, 2024 2.40 Mn
Jun 30, 2024 2.01 Mn
Mar 31, 2024 1.60 Mn
Dec 31, 2023 1.14 Mn
Sep 30, 2023 902,977.00
Jun 30, 2023 838,931.00
Mar 31, 2023 1.19 Mn
Dec 31, 2022 889,355.00
Sep 30, 2022 1.55 Mn
Jun 30, 2022 1.61 Mn
Mar 31, 2022 1.60 Mn
Dec 31, 2021 1.11 Mn
Sep 30, 2021 799,779.00
API Access

Dermata Therapeutics Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=DRMA&period=max&api_key=YOUR_API_KEY